1. Introduction About the Effects on The Brain
The neurodegenerative disorder known as Lou Gehrig’s Disease have a devastating impact on global health care as they cause severe physical deterioration and greater financial burden because of prolonged terminal care. Killing voluntary muscle control, Lou Gehrig’s Disease destroys these nerve cells, leading to complete loss of control and paralysis of voluntary muscles and eventually, loss of control of breathing and death. There are many psychological burdens caused by these diseases. Conventional medical methods can only rely on alleviating and controlling the symptoms of Lou Gehrig’s disease, but there is no stopping its progression. Advanced medical practices are desperately needed to reverse the decline caused by the neurodegenerative disease. Regenerative medicine offers phenomenal promise to achieve long-term healing. UC-MSCs have the potential to be a revolutionary approach to the disruption of the cellular healing process. A modern stem cell clinic has researchers who continuously develop and improve approaches to efficiently use these biomedical tools to impact and improve the quality of life of populations with complex and severe neurological disorders in great need of support.
2. Development of Biology Mechanisms
Motor neurons in Lou Gehrig’s Disease can undergo a complex pathological cascade of cellular destruction and deterioration. The relentless neuron damage caused by excitotoxicity is due to the accumulation and release of glutamate at the synapse. Neuroinflammation and the rapid destruction of neurons in the CNS are triggered by the release of inflammatory mediators and reactive microglia. A critical loss of cellular energy is caused by the increased oxidative intracellular stress caused by mitochondrial dysfunction in addition to cumulative cellular damage. Protein misfolding leads to the toxic buildup of aggregates in neural tissues, which leads to destruction of previously healthy cells. These pathways lead to an agonizing situation for the population in need of support at a stem cell clinic utilizing UC-MSCs. Secretomes from specialized regenerative cells, such as UC-MSCs administered at a stem cell clinic for Lou Gehrig’s disease, are rich in neurotrophic factors. These proteins promote the formation of new neurons and help prevent the apoptosis of neurons. Extracellular vesicles also carry genetic material and can be used to manipulate the cell’s internal pathways. These vesicles can enter the hostile neural environment and help re-establish the favorable biochemical milieu needed to promote neurogenesis.
3. Standard Treatments and their Limitations
At present, the strategies available for the treatment of Lou Gehrig’s Disease have a disheartening focus on prolonging survival by a matter of months. The most widely used of these treatments is Riluzole, which is designed to decrease brain glutamate excitotoxicity. Edaravone is another treatment, which is aimed at decreasing the oxidative stress in the degenerating nervous system. These synthetic treatments have very little tangible benefit on the daily functioning of these patients. Eventually, patients will require a full regimen of supportive procedures, including long-term mechanical ventilation and artificial nutrition via enteral feeding. These treatments have the engrained limitation of being unable to restore even a single motor neuron or even arrest the ongoing decline in neural function. These drugs also only treat single, discrete functions of neural pathology. These drugs also have a very high risk of prolonged adverse effects like gastrointestinal and hepatic disorders. These drawbacks are well known to the medical community, driving the search for UC-MSCs options at a modern stem cell clinic.
4. Justification for Regenerative Strategies
Moving towards more biological treatments is justified by a complete understanding of their added benefits. The use of UC-MSCs therapy at a stem cell clinic is a long-awaited improvement to the biological status quo, offering real hope to patients who are suffering from chronic neuroinflammation, given the active neuroinflammatory process present in most neurodegenerative disorders, including Lou Gehrig’s disease. With specific administration of UC-MSCs at a stem cell clinic for Lou Gehrig’s disease, stem cells actively migrate to concentrated areas of injury of the central nervous system. This special biological homing mechanism is what allows stem cells to be delivered to areas in need of tissue repair. Unlike synthetic drugs, stem cells rely on the pathological microenvironment to adapt and change the profile of their secretome. They are able to help the survival of motor neurons by providing essential neurotrophic factors. In addition, stem cells also modulate microglial polarization, shifting them from a cytotoxic phenotype to a tissue-repair phenotype. The mechanisms of stem cells are able to change the toxic microenvironments of the body.
Figure 1: Limitations of Conventional methods and Benefits of biological approach
5. Future Applications in Thailand
Southeast Asia is quickly becoming a world leader in new and advanced medical procedures. Looking at Thailand for progressive and specialized care for Lou Gehrig’s Disease has its benefits in a combination of supportive regulations and superior clinical care. Thailand has the official designation of a Leading Medical Tourism country due to the advanced and supportive government regulations. With the establishment of an advanced stem cell clinic in Thailand, their strict regulations will be able to effectively control the standards of stem cell services. The combination of supportive regulations and the collaboration of Thai researchers and the international community to enhance stem cell technologies will make stem cell research and UC-MSCs services more effective and less expensive.
6. Overview of Stem Cell Technologies and Stem Cell Services
The progressive and advanced procedures in medicine, like UC-MSCs at a stem cell clinic, are necessary for the treatment of devastating neurodegenerative diseases like Lou Gehrig’s disease. The clear physiological manifestations of Lou Gehrig’s Disease demand the departure from conventional limited pharmacological approaches. UC-MSCs provide an incredible opportunity for a paradigm change in the treatment of neurodegenerative diseases. They offer the possibility of actively combating the inflammation characterizing the disease while also providing the means to preserve essential functioning neurons.